Clinical Trials Directory

Trials / Completed

CompletedNCT04466774

A Comparative, Controlled Study to Evaluate the Lay User Accuracy and Performance of the Dip Home-Based Dipstick Analyzer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
429 (actual)
Sponsor
Healthy.io Ltd. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The Dip Home-Based Dipstick Analyzer (henceforth HBDA) is composed of a kit and a smartphone application. The device will be provided to the subject in a simulated home-use environment. All subjects will be asked to complete the urine test by following the application guidance, including providing a urine sample and scanning the urine strip after placing it on the Color-Board. The user will also complete a questionnaire to collect information regarding the use of the HBDA device. Following the usability test performed by the lay user, the subject's urine sample will be tested by the professional user using the comparator device. The use of the HBDA device will be evaluated for accuracy and identified risks. Additionally, measurable usability criteria for specific, critical steps will be evaluated.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDip Home-Based Dipstick AnalyzerThe Dip Home-Based Dipstick Analyzer is a prescription, in-vitro diagnostic, home use device, which qualitatively and semi-quantitatively measures six urine analytes. The device combines a urine stick kit with an easy to use smartphone application using an image recognition algorithm.
DEVICEUrine analysis predicate device for professional userResults of the experimental HBDA device will be compared to the results of the predicate device tested by a professional user.

Timeline

Start date
2017-03-05
Primary completion
2017-07-30
Completion
2017-09-30
First posted
2020-07-10
Last updated
2020-07-10

Locations

3 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04466774. Inclusion in this directory is not an endorsement.